Evidence map›Paper›PMID 41852340›Full record

ArticleHaematologica2026

Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphoma.

Jeremy Ramdial, Erica Agbadiba, Misha Hawkins, Amy Ayers, Farzaneh Maadani, Indreshpal Kaur, Paolo Strati, Dai Chihara, Qaiser Bashir, Chitra Hosing and 5 more

Abstract read
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jeremy RamdialDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Erica AgbadibaDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Misha HawkinsDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Amy AyersDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Farzaneh MaadaniDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Indreshpal KaurDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Paolo StratiDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Dai ChiharaDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Qaiser BashirDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Chitra HosingDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Chelsea PinnixDept of Radiation-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Sattva NeelapuDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Elizabeth J ShpallDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Yago NietoDept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Sairah AhmedDept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41852340
PMCPMC13530921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.